Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Cytotoxic Activity of Unique Synthesized Five-membered Heterocyclic Compounds Coordinated with Tiopronin Monovalent

Author(s): Naoyuki Sano, Hironori Yoshino, Yoshiaki Sato, Hideo Honma, Christopher E.J. Cordonier and Ikuo Kashiwakura*

Volume 29, Issue 12, 2023

Published on: 17 April, 2023

Page: [957 - 965] Pages: 9

DOI: 10.2174/1381612829666230407094658

Price: $65

Abstract

Background: We recently synthesized a compound in which 5-mercapto-1-methyltetrazole (MM4) was coordinated to tiopronin monovalent (TPN-Au(I)) and reported its cytotoxic activity against human leukemia cells in vitro.

Objective: We further synthesized other heterocyclic compounds coordinated with TPN-Au(I) and assessed their cytotoxic activity against hepatocellular carcinoma HepG2 and lung cancer cell line H1299 in vitro.

Methods: Seven kinds of compounds were synthesized by introducing a five-membered heterocyclic compound into TPN-Au(I). The number of viable cells was counted by a trypan blue dye exclusion assay. Fluorescence conjugated-Annexin V and propidium iodide were used for the apoptosis analysis.

Results: Seven compounds were successfully synthesized. Among these compounds, TPN-Au(I)-MTZ (3- mercapto-1,2,4-triazole), TPN-Au(I)-MMT (2-mercapto-5-methyl-1,3,4-thiadiazole), and TPN-Au(I)-MMTT (2-mercapto-5-methylthio-1,3,4-thiadiazole) effectively suppressed the proliferation and induced apoptosis in HepG2 cells. In addition, TPN-Au(I)-MMTT and TPN-Au(I)-MMT also showed effective cytotoxicity against H1299 cells.

Conclusion: The present results showed that introduction of some five-membered heterocyclic compounds, especially MMT and MMTT, to TPN-Au(I) improved the cytotoxicity against solid cancer cells.

« Previous Next »
[1]
Nakaya A, Sagawa M, Muto A, Uchida H, Ikeda Y, Kizaki M. The gold compound auranofin induces apoptosis of human multiple myeloma cells through both down-regulation of STAT3 and inhibition of NF-κB activity. Leuk Res 2011; 35(2): 243-9.
[http://dx.doi.org/10.1016/j.leukres.2010.05.011] [PMID: 20542334]
[2]
Florea AM, Büsselberg D. Cisplatin as an anti-tumor drug: Cellular mechanisms of activity, drug resistance and induced side effects. Cancers 2011; 3(1): 1351-71.
[http://dx.doi.org/10.3390/cancers3011351] [PMID: 24212665]
[3]
Bhatia M, McGrath KL, Di Trapani G, et al. The thioredoxin system in breast cancer cell invasion and migration. Redox Biol 2016; 8: 68-78.
[http://dx.doi.org/10.1016/j.redox.2015.12.004] [PMID: 26760912]
[4]
Simon F. Deposition of gold without external current source. Gold Bull 1993; 26(1): 14-23.
[http://dx.doi.org/10.1007/BF03214724]
[5]
Watanabe H, Abe S, Honma H. Gold wire bondability of electroless gold plating using disulfiteaurate complex. J Appl Electrochem 1998; 28(5): 525-9.
[http://dx.doi.org/10.1023/A:1003273329474]
[6]
Brust M, Walker M, Bethell D, Schiffrin DJ, Whyman R. Synthesis of thiol-derivatised gold nanoparticles in a two-phase liquid-liquid system. J Chem Soc Chem Commun 1994; 0(7): 801-2.
[http://dx.doi.org/10.1039/C39940000801]
[7]
Moussa M, Papatsoris AG, Abou Chakra M, Moussa Y. Update on cystine stones: Current and future concepts in treatment. Intractable Rare Dis Res 2020; 9(2): 71-8.
[http://dx.doi.org/10.5582/irdr.2020.03006] [PMID: 32494553]
[8]
Simpson CA, Farrow CL, Tian P, et al. Tiopronin gold nanoparticle precursor forms aurophilic ring tetramer. Inorg Chem 2010; 49(23): 10858-66.
[http://dx.doi.org/10.1021/ic101146e] [PMID: 21067183]
[9]
Endo H, Tashiro K, Ma H, et al. Direct gold plating selectively on UV modified polymer film using tiopronin-gold. J Electrochem Soc 2015; 162(6): D193-8.
[http://dx.doi.org/10.1149/2.0441506jes]
[10]
Kobayashi Y, Cordonier CEJ, Noda Y, et al. Tailored cell sheet engineering using microstereolithography and electrochemical cell transfer. Sci Rep 2019; 9(1): 10415.
[http://dx.doi.org/10.1038/s41598-019-46801-9] [PMID: 31320678]
[11]
Sano N, Yoshino H, Sato Y, Honma H, Cordonier CEJ, Kashiwakura I. Cytotoxic activity of a unique monomeric heterogeneous two-coordinate ligand monovalent gold complex with tiopronin and a heterocyclic mercapto-tetrazole compound. Curr Med Chem 2022; 29(22): 3973-82.
[http://dx.doi.org/10.2174/0929867328666211018094206] [PMID: 34666640]
[12]
Wetzel C, Lonneman M, Wu C. Polypharmacological drug actions of recently FDA approved antibiotics. Eur J Med Chem 2021; 209: 112931.
[http://dx.doi.org/10.1016/j.ejmech.2020.112931] [PMID: 33127170]
[13]
Georgiou N, Gkalpinos VK, Katsakos SD, Vassiliou S, Tzakos AG, Mavromoustakos T. Rational design and synthesis of AT1R antagonists. Molecules 2021; 26(10): 2927.
[http://dx.doi.org/10.3390/molecules26102927] [PMID: 34069122]
[14]
Ismail MAH, Barker S, Abou El Ella DA, Abouzid KAM, Toubar RA, Todd MH. Design and synthesis of new tetrazolyl and carboxy-biphenylylmethyl-quinazolin-4-one derivatives as angiotensin II AT1 receptor antagonists. J Med Chem 2006; 49(5): 1526-35.
[http://dx.doi.org/10.1021/jm050232e] [PMID: 16509571]
[15]
Ostrovskii VA, Trifonov RE, Popova EA. Medicinal chemistry of tetrazoles. Russian Chemical Bulletin, International Edition 2012; 61(4): 768-80.
[http://dx.doi.org/10.1007/s11172-012-0108-4]
[16]
Serban G, Stanasel O, Serban E, Bota S. 2-Amino-1,3,4-thiadiazole as a potential scaffold for promising antimicrobial agents. Drug Des Devel Ther 2018; 12: 1545-66.
[http://dx.doi.org/10.2147/DDDT.S155958] [PMID: 29910602]
[17]
Serban G. Future prospects in the treatment of parasitic diseases: 2-Amino-1,3,4-thiadiazoles in leishmaniasis. Molecules 2019; 24(8): 1557.
[http://dx.doi.org/10.3390/molecules24081557] [PMID: 31010226]
[18]
Alwan SM. Synthesis and preliminary antimicrobial activities of new arylideneamino-1,3,4-thiadiazole-(thio/dithio)-acetamido cephalosporanic acids. Molecules 2012; 17(1): 1025-38.
[http://dx.doi.org/10.3390/molecules17011025] [PMID: 22262201]
[19]
Serban G. Synthetic compounds with 2-Amino-1,3,4-thiadiazole moiety against viral infections. Molecules 2020; 25(4): 942.
[http://dx.doi.org/10.3390/molecules25040942]
[20]
Koizumi R, Kusama Y, Asai Y, Yoshiaki G, Muraki Y, Ohmagari N. Effects of the cefazolin shortage on the sales, cost, and appropriate use of other antimicrobials. BMC Health Serv Res 2021; 21(1): 1118.
[http://dx.doi.org/10.1186/s12913-021-07139-z] [PMID: 34663315]
[21]
Takemura W, Tashiro S, Hayashi M, et al. Cefmetazole as an alternative to carbapenems against extended-spectrum beta-lactamase-producing Escherichia coli infections based on in vitro and in vivo pharmacokinetics/pharmacodynamics experiments. Pharm Res 2021; 38(11): 1839-46.
[http://dx.doi.org/10.1007/s11095-021-03140-7] [PMID: 34853981]
[22]
Xia J, Yang L, Dong L, et al. Cefminox, a dual agonist of prostacyclin receptor and peroxisome proliferator-activated receptorgamma identified by virtual screening, has therapeutic efficacy against hypoxia-induced pulmonary hypertension in rats. Front Pharmacol 2018; 9: 134.
[http://dx.doi.org/10.3389/fphar.2018.00134] [PMID: 29527168]
[23]
The Japanese Pharmacopoeia. Ministry of Health, Labour and Welfare. 2021. Available from: https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000066597.html#:~:text
[24]
DeFronzo RA, Inzucchi S, Abdul-Ghani M, Nissen SE. Pioglitazone: The forgotten, cost-effective cardioprotective drug for type 2 diabetes. Diab Vasc Dis Res 2019; 16(2): 133-43.
[http://dx.doi.org/10.1177/1479164118825376] [PMID: 30706731]
[25]
Thangam EB, Jemima EA, Singh H, et al. The role of histamine receptors in mast cell-mediated allergy and inflammation: The hunt for new therapeutic targets. Front Immunol 2018; 13(9): 1873.
[http://dx.doi.org/10.3389/fimmu.2018.01873]
[26]
Furutani K, Aihara T, Nakamura E, et al. Crucial role of histamine for regulation of gastric acid secretion ascertained by histidine decarboxylase-knockout mice. J Pharmacol Exp Ther 2003; 307(1): 331-8.
[http://dx.doi.org/10.1124/jpet.103.052019] [PMID: 12893847]
[27]
Shim YK, Kim N. The effect of H2 receptor antagonist in acid inhibition and its clinical efficacy. Korean J Gastroenterol 2017; 70(1): 4-12.
[http://dx.doi.org/10.4166/kjg.2017.70.1.4] [PMID: 28728310]
[28]
Malagelada JR, Cortot AH. H2-receptor antagonists in perspective. Mayo Clin Proc 1978; 53(3): 184-90.
[29]
Thayer AM. Drug Repurposing Finding new uses for approved drugs and shelved drug candidates is gaining steam as a pharmaceutical development strategy. Chem Eng News 2012; 90: 15-25. Available from: https://cen.acs.org
[30]
Kumar R, Kumar V, Lee KW. A computational drug repurposing approach in identifying the cephalosporin antibiotic and antihepatitis C drug derivatives for COVID-19 treatment Comput Biol Med 2021; 130: 104186.
[31]
Pillaiyar T, Meenakshisundaram S, Manickam M, Sankaranarayanan M. A medicinal chemistry perspective of drug repositioning: Recent advances and challenges in drug discovery. Eur J Med Chem 2020; 195: 112275.
[http://dx.doi.org/10.1016/j.ejmech.2020.112275] [PMID: 32283298]
[32]
Kido K, Matsumaru N, Tsukamoto K. Health technology assessment in Japan: A pharmaceutical industry perspective. Ther Innov Regul Sci 2019; 53(4): 472-80.
[http://dx.doi.org/10.1177/2168479018791136] [PMID: 30157674]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy